These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 12866281

  • 1. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May 29; 145(22):51. PubMed ID: 12866281
    [No Abstract] [Full Text] [Related]

  • 2. [Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschr Med; 2003 May 29; 145(22):50-1. PubMed ID: 12866280
    [No Abstract] [Full Text] [Related]

  • 3. [Respiratory allergies in the child and the adult].
    Magnan A.
    Rev Prat; 2004 Jan 31; 54(2):189-98. PubMed ID: 15086062
    [No Abstract] [Full Text] [Related]

  • 4. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H.
    Laryngorhinootologie; 2005 Jan 31; 84(1):30-41. PubMed ID: 15647976
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy of ebastine 10mg and 20mg once daily with that of cetirizine 10mg once daily in adults with seasonal allergic rhinitis. A multicentre double-blind study.
    Cohen B, Gehanno P.
    Drugs; 1996 Jan 31; 52 Suppl 1():26-9. PubMed ID: 8828023
    [No Abstract] [Full Text] [Related]

  • 6. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May 31; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 7. [Peripheral anticholinergic syndrome].
    Valencia Zavala MP, Vega Robledo GB, Sánchez Olivas JA, Sánchez Olivas MA, Montes Montes J, Duarte Díaz RJ, León Oviedo C.
    Rev Alerg Mex; 2007 May 31; 54(2):66-9. PubMed ID: 17542247
    [Abstract] [Full Text] [Related]

  • 8. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P, Zieglmayer R, Horak F.
    Curr Med Res Opin; 2004 Jun 31; 20(6):891-902. PubMed ID: 15200748
    [Abstract] [Full Text] [Related]

  • 9. [Clinical research of Ibudilast on treating the steroid resistant allergic rhinitis].
    Luo H, Tao Z, Yan N, Liang J, Wang P, Wang J.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan 31; 23(2):63-6. PubMed ID: 19452709
    [Abstract] [Full Text] [Related]

  • 10. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Salmun LM, Gates D, Scharf M, Greiding L, Ramon F, Heithoff K.
    Clin Ther; 2000 May 31; 22(5):573-82. PubMed ID: 10868555
    [Abstract] [Full Text] [Related]

  • 11. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA, Riethuisen JM, Moulaert B, DeVos C.
    Ann Allergy Asthma Immunol; 2002 Feb 31; 88(2):190-7. PubMed ID: 11868924
    [Abstract] [Full Text] [Related]

  • 12. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
    Gehanno P, Bremard-Oury C, Zeisser P.
    Ann Allergy Asthma Immunol; 1996 Jun 31; 76(6):507-12. PubMed ID: 8673684
    [Abstract] [Full Text] [Related]

  • 13. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
    Ciprandi G, Tosca MA, Milanese M, Ricca V.
    Eur Ann Allergy Clin Immunol; 2004 Jun 31; 36(6):237-40. PubMed ID: 15329007
    [Abstract] [Full Text] [Related]

  • 14. Ebastine in perennial allergic rhinitis.
    Picado Vallés C, Cadahia García A, Cisteró Bahima A, Cano Cantudo L, Sanz Amaro A, Zayas Sanza JM.
    Ann Allergy; 1991 Dec 31; 67(6):615-8. PubMed ID: 1684273
    [Abstract] [Full Text] [Related]

  • 15. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
    Van Cauwenberge P, De Belder T, Sys L.
    Expert Opin Pharmacother; 2004 Aug 31; 5(8):1807-13. PubMed ID: 15264995
    [Abstract] [Full Text] [Related]

  • 16. Comparison of ebastine with cetirizine.
    Volkerts ER.
    Ann Allergy Asthma Immunol; 1997 Nov 31; 79(5):465-6. PubMed ID: 9396983
    [No Abstract] [Full Text] [Related]

  • 17. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
    Ratner P, Falqués M, Chuecos F, Esbrí R, Gispert J, Peris F, Luria X, Rosales MJ.
    Int Arch Allergy Immunol; 2005 Dec 31; 138(4):312-8. PubMed ID: 16224195
    [Abstract] [Full Text] [Related]

  • 18. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis.
    Nunes C, Ladeira S.
    J Investig Allergol Clin Immunol; 2000 Dec 31; 10(1):20-3. PubMed ID: 10780795
    [Abstract] [Full Text] [Related]

  • 19. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
    Ratner PH, Lim JC, Georges GC.
    J Allergy Clin Immunol; 2000 Jun 31; 105(6 Pt 1):1101-7. PubMed ID: 10856142
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep 31; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.